Biggest News Aggregation in the World
📰 Nasdaq Nbse News

Nasdaq Nbse News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Nbse. Real-time updates on events, politics, business and more.

Critical Comparison: NeuBase Therapeutics (NASDAQ:NBSE) vs. Gemini Therapeutics (NASDAQ:GMTX)

NeuBase Therapeutics (NASDAQ:NBSE – Get Free Report) and Gemini Therapeutics (NASDAQ:GMTX – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Earnings and Valuation This table compares NeuBase Therapeutics […]
United Kingdom United States Neubase Therapeutics Inc Gemini Therapeutics Inc Neubase Therapeutics Get Free Report

NeuBase Therapeutics (NASDAQ:NBSE) Shares Down 3.3%

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) shares dropped 3.3% on Thursday . The stock traded as low as $0.68 and last traded at $0.69. Approximately 37,086 shares changed hands during trading, a decline of 50% from the average daily volume of 74,431 shares. The stock had previously closed at $0.71. NeuBase Therapeutics Price […]
New York United States Renaissance Technologies Royal Bank Worth Venture Partners First Manhattan Co

NeuBase Therapeutics (NASDAQ:NBSE) Shares Down 3.3%

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) shares traded down 3.3% during trading on Thursday . The stock traded as low as $0.68 and last traded at $0.69. 37,086 shares were traded during mid-day trading, a decline of 50% from the average session volume of 74,431 shares. The stock had previously closed at $0.71. […]
New York United States Renaissance Technologies Royal Bank Neubase Therapeutics Company Profile Worth Venture Partners

Reviewing NeuBase Therapeutics (NASDAQ:NBSE) and Aditxt (NASDAQ:ADTX)

NeuBase Therapeutics (NASDAQ:NBSE – Get Free Report) and Aditxt (NASDAQ:ADTX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk. Profitability This table compares NeuBase Therapeutics and Aditxt’s […]
United States Leland Stanford Junior University Aditxt Inc Neubase Therapeutics Inc Aditx Therapeutics Inc Loma Linda University

Short Interest in NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Drops By 53.9%

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 8,900 shares, a decrease of 53.9% from the October 15th total of 19,300 shares. Based on an average trading volume of 2,280,000 shares, the days-to-cover ratio […]
New York United States Corp Symetryx First Manhattan Co Neubase Therapeutics Inc Royal Bank

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Insider Selling: NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Major Shareholder Sells 74,852 Shares of Stock

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) major shareholder Corp Symetryx sold 74,852 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $1.80, for a total transaction of $134,733.60. Following the transaction, the insider now owns 605,149 shares in the company, valued […]
New York United States Worth Venture Partners First Manhattan Co Neubase Therapeutics Inc Securities Exchange Commission

FY2023 EPS Estimates for NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Raised by Analyst

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) – Equities researchers at Chardan Capital increased their FY2023 earnings per share estimates for shares of NeuBase Therapeutics in a research note issued to investors on Wednesday, August 16th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($5.19) for the […]
New York United States Worth Venture Partners First Manhattan Co Royal Bank Renaissance Technologies

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Update

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 71,500 shares, a growth of 108.5% from the June 15th total of 34,300 shares. Based on an average trading volume of 72,200 shares, […]
New York United States Worth Venture Partners Renaissance Technologies Royal Bank First Manhattan Co

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Down 93.8% in June

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 34,300 shares, a drop of 93.8% from the May 31st total of 554,800 shares. Based on an average trading volume of 62,600 shares, the short-interest ratio is […]
New York United States First Manhattan Co Neubase Therapeutics Inc Royal Bank Worth Venture Partners

CM Management LLC Sells 100,000 Shares of NeuBase Therapeutics, Inc. (NASDAQ:NBSE)

CM Management LLC lessened its holdings in NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Rating) by 22.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 350,000 shares of the company’s stock after selling 100,000 shares during the period. CM Management LLC owned approximately 1.06% […]
New York United States Cm Management First Manhattan Co Worth Venture Partners Renaissance Technologies
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science